04/26/2024
4:10 PM | Unicycive Therapeutics (Filer)
| Form DEF 14A | |
04/26/2024
4:11 PM | Unicycive Therapeutics (Filer)
| Form ARS | |
04/26/2024
4:12 PM | Unicycive Therapeutics (Filer)
| Form DEFA14A | |
04/17/2024
3:31 PM | Gupta Shalabh K. (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:31 PM | Gupta Pramod (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:32 PM | Jermasek Douglas (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:33 PM | Townsend John (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/28/2024
3:06 PM | Unicycive Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/20/2024
4:09 PM | Unicycive Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/14/2024
5:41 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Unicycive Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
2:18 PM | ARMISTICE CAPITAL, LLC (Filed by)
Unicycive Therapeutics (Subject)
| Form SC 13G/A | |
01/22/2024
3:27 PM | Logos Global Management LP (Filed by)
Unicycive Therapeutics (Subject)
| Form SC 13G | |
12/08/2023
3:36 PM | Unicycive Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/14/2023
3:20 PM | Unicycive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/23/2023
10:12 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2023
3:05 PM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
3:30 PM | Aggarwal Gaurav (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
3:32 PM | Ryan John L (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
3:33 PM | Kenkare-Mitra Sara (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
3:34 PM | Laumas Sandeep (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/07/2023
3:05 PM | Kenkare-Mitra Sara (Reporting)
Unicycive Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/06/2023
8:16 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2023
3:45 PM | Jermasek Douglas (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
3:46 PM | Townsend John (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
3:47 PM | Gupta Shalabh K. (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
3:47 PM | Gupta Pramod (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
8:19 PM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
4:12 PM | Unicycive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023
11:15 PM | Unicycive Therapeutics (Filer)
| Form EFFECT | |
07/31/2023
3:15 PM | Unicycive Therapeutics (Filer)
Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2023
5:05 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2023
3:30 PM | Unicycive Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13G | |
07/13/2023
7:42 PM | Aggarwal Gaurav (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2023
6:33 PM | Jermasek Douglas (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2023
6:01 PM | Gupta Pramod (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2023
5:10 PM | Gupta Shalabh K. (Reporting)
Unicycive Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
6:49 PM | Unicycive Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
07/06/2023
4:23 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Unicycive Therapeutics (Subject)
| Form SC 13G | |
07/06/2023
3:30 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Unicycive Therapeutics (Subject)
| Form SC 13G | |
06/26/2023
3:15 PM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
8:54 PM | Unicycive Therapeutics (Filer)
| Form DEFA14A | |
Elon to Transform U.S. Economy? (Ad) A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. |
05/23/2023
3:05 PM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2023
9:30 AM | Unicycive Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2023
7:56 AM | Unicycive Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/16/2023
5:05 AM | Unicycive Therapeutics (Filer)
| Form NT 10-Q | |
